Neomed Management
Overview
NeoMed Management is an international investment firm, exclusively focussing on the healthcare and life science industry. Founded in 1996, NeoMed has established four funds, with total committed capital exceeding $200 million.
Investment Focus
- Innovative solutions in healthcare and life sciences
- Strong growth potential
- Experienced management teams
- Scalable business models
- Clear regulatory pathways
Portfolio Companies
Get the full list of 54,000+ investors
Neomed Management and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Neomed Management
What sectors does Neomed Management invest in?
Neomed Management invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Oslo, Norway. Neomed Management is listed as a vc in the ConnectSafely investor database.
What stage does Neomed Management invest at?
Neomed Management backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 1M - 50M.
Which regions does Neomed Management invest in?
Neomed Management invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Neomed Management invested in?
Neomed Management's portfolio includes Sequana Medical NV, Biocryst Pharmaceuticals, Aptinyx Inc, Aptose Biosciences and Aptose Biosciences Inc.
Last updated · Source: ConnectSafely investor database
